Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74.4M
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
+88.1K
-
Total reported value, excl. options
-
$284M
-
Value change
-
+$903K
-
Number of buys
-
35
-
Number of sells
-
-17
-
Price
-
$10.98
Significant Holders of Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) as of Q2 2018
61 filings reported holding CRVS - Corvus Pharmaceuticals, Inc. - Common Stock as of Q2 2018.
Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
of 74.4M outstanding shares and own 34.84% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5.97M shares), Novo Holdings A/S (4.42M shares), ADAMS STREET PARTNERS LLC (3.28M shares), FMR LLC (2.48M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2M shares), BVF INC/IL (1.89M shares), BlackRock Inc. (1.12M shares), VANGUARD GROUP INC (664K shares), Rock Springs Capital Management LP (575K shares), and COWEN INC. (534K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.